Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Exp Gerontol

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    September 2018
  1. DRYGALSKI K, Fereniec E, Korycinski K, Chomentowski A, et al
    Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials.
    Exp Gerontol. 2018;113:36-47.
    PubMed     Text format    


    August 2018
  2. HUTTER-SCHMID B, Humpel C
    Primary mouse brain pericytes isolated from transgenic Alzheimer mice spontaneously differentiate into a CD11b(+) microglial-like cell type in vitro.
    Exp Gerontol. 2018 Aug 9. pii: S0531-5565(18)30435.
    PubMed     Text format     Abstract available


    July 2018
  3. TOROSYAN N, Sethanandha C, Grill JD, Dilley ML, et al
    Changes in regional cerebral blood flow associated with a 45day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.
    Exp Gerontol. 2018;111:118-121.
    PubMed     Text format     Abstract available


    June 2018
  4. SHEKHAR S, Yadav Y, Singh AP, Pradhan R, et al
    Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway.
    Exp Gerontol. 2018 Jun 27. pii: S0531-5565(18)30302.
    PubMed     Text format     Abstract available


  5. BUFFA R, Mereu E, Putzu P, Mereu RM, et al
    Corrigendum to "Lower lean mass and higher percent fat mass in patients with Alzheimer's disease" [Exp. Gerontol. 58 (2014) 30-33].
    Exp Gerontol. 2018 Jun 2. pii: S0531-5565(18)30330.
    PubMed     Text format    


    March 2018
  6. KUNUTSOR SK, Laukkanen JA, Burgess S
    Genetically elevated gamma-glutamyltransferase and Alzheimer's disease.
    Exp Gerontol. 2018 Mar 2. pii: S0531-5565(18)30042.
    PubMed     Text format     Abstract available


    January 2018
  7. HENRIQUES AD, Benedet AL, Camargos EF, Rosa-Neto P, et al
    Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.
    Exp Gerontol. 2018 Jan 4. pii: S0531-5565(17)30411.
    PubMed     Text format     Abstract available


    December 2017
  8. LE PAGE A, Dupuis G, Frost EH, Larbi A, et al
    Role of the peripheral innate immune system in the development of Alzheimer's disease.
    Exp Gerontol. 2017 Dec 21. pii: S0531-5565(17)30541.
    PubMed     Text format     Abstract available


    November 2017
  9. MEREU E, Succa V, Buffa R, Sanna C, et al
    Total body and arm bioimpedance in patients with Alzheimer's disease.
    Exp Gerontol. 2017 Nov 21. pii: S0531-5565(17)30668.
    PubMed     Text format     Abstract available


    October 2017
  10. YASHIN AI, Fang F, Kovtun M, Wu D, et al
    Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.
    Exp Gerontol. 2017 Oct 26. pii: S0531-5565(17)30424.
    PubMed     Text format     Abstract available


  11. MATHYS J, Gholamrezaee M, Henry H, von Gunten A, et al
    Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Exp Gerontol. 2017 Oct 17. pii: S0531-5565(17)30465.
    PubMed     Text format     Abstract available


  12. FARINA N, Jerneren F, Turner C, Hart K, et al
    Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
    Exp Gerontol. 2017 Oct 9. pii: S0531-5565(17)30374.
    PubMed     Text format     Abstract available


    August 2017
  13. SCARABINO D, Broggio E, Gambina G, Corbo RM, et al
    Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2017 Aug 18. pii: S0531-5565(17)30445.
    PubMed     Text format     Abstract available


    July 2017
  14. CROTEAU E, Castellano CA, Fortier M, Bocti C, et al
    A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Exp Gerontol. 2017 Jul 11. pii: S0531-5565(17)30228.
    PubMed     Text format     Abstract available


    May 2017
  15. KWON Y
    Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
    Exp Gerontol. 2017 May 17. pii: S0531-5565(17)30214.
    PubMed     Text format     Abstract available


    March 2017
  16. LI J, Cui X, Ma X, Wang Z, et al
    rBTI reduced beta-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
    Exp Gerontol. 2017;89:78-86.
    PubMed     Text format     Abstract available


    February 2017
  17. HUANG M, Jiang X, Liang Y, Liu Q, et al
    Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of beta-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Exp Gerontol. 2017;91:25-33.
    PubMed     Text format     Abstract available


  18. MACKLIN L, Griffith CM, Cai Y, Rose GM, et al
    Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Exp Gerontol. 2017;88:9-18.
    PubMed     Text format     Abstract available


    January 2017
  19. GARD PR, Fidalgo S, Lotter I, Richardson C, et al
    Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer's disease.
    Exp Gerontol. 2017 Jan 6. pii: S0531-5565(17)30006.
    PubMed     Text format     Abstract available


    December 2016
  20. SCARABINO D, Broggio E, Gambina G, Pelliccia F, et al
    Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimer's disease.
    Exp Gerontol. 2016 Dec 27. pii: S0531-5565(16)30423.
    PubMed     Text format     Abstract available


  21. BARRON M, Gartlon J, Dawson LA, Atkinson PJ, et al
    A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease.
    Exp Gerontol. 2016 Dec 12. pii: S0531-5565(16)30580.
    PubMed     Text format     Abstract available


  22. NAKAGAWA T, Hasegawa Y, Uekawa K, Kim-Mitsuyama S, et al
    Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
    Exp Gerontol. 2016 Dec 1. pii: S0531-5565(16)30318.
    PubMed     Text format     Abstract available


    November 2016
  23. TARANTINI S, Tran CH, Gordon GR, Ungvari Z, et al
    Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.
    Exp Gerontol. 2016 Nov 11. pii: S0531-5565(16)30399.
    PubMed     Text format     Abstract available


    September 2016
  24. ZHANG ZX, Zhao RP, Wang DS, Wang AN, et al
    Fuzhisan ameliorates Abeta production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Exp Gerontol. 2016;84:88-95.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: